Evidence map›Paper›PMID 37511135›Full record

ArticleInternational journal of molecular sciences2023

Jing Xie, Ming-Rong Yang, Xia Hu, Zi-Shan Hong, Yu-Ying Bai, Jun Sheng, Yang Tian, Chong-Ying Shi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Frontiers in pharmacology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jing XieCollege of Food Science and Technology, Yunnan Agricultural University, Kunming 650201, China.
Ming-Rong YangCollege of Food Science and Technology, Yunnan Agricultural University, Kunming 650201, China.
Xia HuCollege of Food Science and Technology, Yunnan Agricultural University, Kunming 650201, China.
Zi-Shan HongCollege of Food Science and Technology, Yunnan Agricultural University, Kunming 650201, China.
Yu-Ying BaiCollege of Food Science and Technology, Yunnan Agricultural University, Kunming 650201, China.
Jun ShengCollege of Food Science and Technology, Yunnan Agricultural University, Kunming 650201, China.
Yang TianEngineering Research Center of Development and Utilization of Food and Drug Homologous Resources, Ministry of Education, Yunnan Agricultural University, Kunming 650201, China.
Chong-Ying ShiCollege of Food Science and Technology, Yunnan Agricultural University, Kunming 650201, China.
Yunnan Agricultural University · CN

Funding

Industrial Technology Leading Talent Progrem of the Ten Thousand People of Yunnan Province A3032021174Major Project of Science and Technology Department of Yunnan Province 202002AA100005Major Project of Science and Technology Department of Yunnan Province 202102AE090027-2Special provincial and municipal integration in Yunnan Province 202302AN360002YEFICRC project of Yunnan provincial key programs 2019ZG009
6 · The paper itself

Abstract

A major active constituent of

Indexed as

GliomaMoringa oleiferaApoptosisCell CycleCell Cycle CheckpointsCell Cycle ProteinsCell Line, TumorCell ProliferationHumansIsothiocyanatesCell Cycle ProteinsIsothiocyanatesapoptosiscell cycleglioma U251 cellsMoringa oleifera Lam. isothiocyanatequinazolinone

Identifiers

PMID37511135
PMCPMC10379366
OpenAlexW4384202777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.